Diagnosing and managing scleroderma-related pulmonary arterial hypertension

被引：4

作者：

Athanasiou, Katherine Alexis ^{[1
,2
]}

Sahni, Sonu ^{[3
,4
]}

Rana, Amrinder ^{[3
,4
]}

Talwar, Arunabh ^{[3
,4
]}

机构：

[1] Arthrit Inst Long Isl, Rheumatol, Hicksville, NY 11801 USA

[2] Northwell Hlth Syst, New Hyde Pk, NY 11040 USA

[3] Dept Pulm Crit Care & Sleep Med, New Hyde Pk, NY USA

[4] Adv Lung Dis Ctr, New Hyde Pk, NY USA

来源：

JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2017年 / 30卷 / 09期

关键词：

pulmonary arterial hypertension; scleroderma; systemic sclerosis; autoimmune disease; right heart catheterization; vasodilation; RECEPTOR ANTAGONIST BOSENTAN; SYSTEMIC-SCLEROSIS; RISK-FACTORS; DOUBLE-BLIND; DISEASE; ECHOCARDIOGRAPHY; TREPROSTINIL; PREDICTORS; SURVIVAL; EXERCISE;

D O I：

10.1097/01.JAA.0000522129.93995.13

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Scleroderma is an uncommon autoimmune disease of unknown cause that may affect any organ system in the body. Patients with scleroderma are prone to developing pulmonary complications, including pulmonary arterial hypertension (PAH), that are the leading cause of death in this population. This article describes scleroderma-related PAH and its diagnosis and management.

引用

页码：11 / 18

页数：8

共 50 条

[31] The Challenge of Diagnosing and Managing Pulmonary Arterial Hypertension in Systemic Sclerosis with Interstitial Lung Disease
Zanatta, Elisabetta
Marra, Martina Perazzolo
Famoso, Giulia
Balestro, Elisabetta
Giraudo, Chiara
Calabrese, Fiorella
Rea, Federico
Doria, Andrea
PHARMACEUTICALS, 2022, 15 (09)
[32] Endothelin receptor antagonism - Role in the treatment of pulmonary arterial hypertension related to scleroderma
Kabunga, Peter
Coghlan, Gerry
DRUGS, 2008, 68 (12) : 1635 - 1645
[33] Age and risk of pulmonary arterial hypertension in scleroderma
Schachna, L
Wigley, FM
Chang, B
White, B
Wise, RA
Gelber, AC
CHEST, 2003, 124 (06) : 2098 - 2104
[34] Bosentan in pulmonary arterial hypertension secondary to scleroderma
Joglekar, A
Tsai, FS
McCloskey, DA
Wilson, JE
Seibold, JR
Riley, DJ
JOURNAL OF RHEUMATOLOGY, 2006, 33 (01) : 61 - 68
[35] Thyroid function, pulmonary arterial hypertension and scleroderma
Marasini, B
Massarotti, M
Cossutta, R
AMERICAN JOURNAL OF MEDICINE, 2005, 118 (03): : 322 - 323
[36] Detection of pulmonary arterial hypertension in scleroderma patients
Yatsyshyn, N.
Yatsyshyn, R. I.
Neyko, Y.
JOURNAL OF HYPERTENSION, 2008, 26 : S307 - S307
[37] Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension
Mathai, S. C.
Bueso, M.
Hummers, L. K.
Boyce, D.
Lechtzin, N.
Le Pavec, J.
Campo, A.
Champion, H. C.
Housten, T.
Forfia, P. R.
Zaiman, A. L.
Wigley, F. M.
Girgis, R. E.
Hassoun, P. M.
EUROPEAN RESPIRATORY JOURNAL, 2010, 35 (01) : 95 - 104
[38] Prevalence of exercise pulmonary arterial hypertension in scleroderma
Luis Callejas-Rubio, Jose
Moreno-Escobar, Eduardo
Martin de la Fuente, Pilar
Perez, Lourdes Lopez
Rios Fernandez, Raquel
Sanchez-Cano, Daniel
Pomares Mora, Jose
Ortego-Centeno, Norberto
JOURNAL OF RHEUMATOLOGY, 2008, 35 (09) : 1812 - 1816
[39] Advancements in diagnosis of pulmonary arterial hypertension in scleroderma
Steen, V
ARTHRITIS AND RHEUMATISM, 2005, 52 (12): : 3698 - 3700
[40] Sildenafil in the treatment of pulmonary arterial hypertension in scleroderma
Gokhale, S.
Kumar, U.
Handa, R.
Yadav, R.
Srinivas, V.
Kumar, A.
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 209 - 209

← 1 2 3 4 5 →